In recent years, the intricate interplay between inflammation, the microbiota, and cancer progression has emerged as a focal point in scientific inquiry. This special issue, titled "Inflammation, Microbiota, and Cancer Progression," seeks to delve into this dynamic and complex relationship, providing a platform for researchers to explore the nuances and implications of these interconnected factors.

The intersection of inflammation and the microbiota in the context of cancer progression has garnered increasing attention due to its potential impact on disease development, prognosis, and therapeutic interventions. The intricate crosstalk between inflammatory processes and the microbiome within the tumor microenvironment has unveiled novel avenues for understanding and potentially modulating cancer progression.

The primary aim of this special issue is to consolidate and disseminate cutting-edge research that elucidates the intricate connections between inflammation, the microbiota, and the intricate landscape of cancer progression. By providing a dedicated platform, we aim to foster a deeper understanding of the underlying mechanisms, identify potential biomarkers, and explore therapeutic interventions that may arise from this multifaceted relationship. The significance of this endeavor lies in its potential to drive advancements in cancer research and contribute to the development of targeted therapeutic strategies.

The special issue invites contributions covering a spectrum of research subjects within the realms of inflammation, microbiota, and cancer progression.

We welcome diverse contributions, including original research articles, mini review, comprehensive review papers, insightful methodology papers, and succinct short communications. This inclusive approach aims to facilitate a comprehensive exploration of the subject matter, encouraging researchers to present novel findings, critical reviews, and methodological advancements.